Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 3432750, 13 pages
https://doi.org/10.1155/2017/3432750
Review Article

Oral Chinese Herbal Medicine as an Adjuvant Treatment for Chemotherapy, or Radiotherapy, Induced Myelosuppression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

1School of Basic Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
2Department of Pharmacology, Guiyang Medical University, Guiyang, Guizhou, China
3Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China

Correspondence should be addressed to Qi Wang; moc.qq@mctiqw and Shuiqing Huang; nc.ude.mcuzg@qsh

Received 3 November 2016; Revised 8 February 2017; Accepted 7 March 2017; Published 10 August 2017

Academic Editor: Kieran Cooley

Copyright © 2017 Bonan Hou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Lu, S. Zhu, L. Qian et al., “Activated expression of the chemokine Mig after chemotherapy contributes to chemotherapy-induced bone marrow suppression and lethal toxicity,” Blood, vol. 119, no. 21, pp. 4868–4877, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Han, Y. Yu, and Y. L. Xin, “Local signals in stem cell-based bone marrow regeneration,” Cell Research, vol. 16, no. 2, pp. 189–195, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Heuer and D. Blumenberg, “Management of bleeding in a multi-transfused patient with positive HLA class I alloantibodies and thrombocytopenia associated with platelet dysfunction refractory to transfusion of cross-matched platelets,” Blood Coagulation and Fibrinolysis, vol. 16, no. 4, pp. 287–290, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Jia, H. Du, M. Yao et al., “Chinese herbal medicine for myelosuppression induced by chemotherapy or radiotherapy: A systematic review of randomized controlled trials,” Evidence-based Complementary and Alternative Medicine, vol. 2015, Article ID 690976, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. K. K. L. Chan, T. J. Yao, B. Jones et al., “The use of Chinese herbal medicine to improve quality of life in women undergoing chemotherapy for ovarian cancer: A double-blind placebo-controlled randomized trial with immunological monitoring,” Annals of Oncology, vol. 22, no. 10, pp. 2241–2249, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. H. W. Chen, W. Shi, and X. G. Li, “Effect of Chinese Herbal Compound Combining Chemotherapy on Recurrence Breast Cancer,” Liaoning Journal of traditional Chinese Medicine, vol. 42, no. 5, pp. 1003–1005, 2015. View at Google Scholar
  7. L. L. Chen, A Study of Effect Yiliu Decocotion Combined with Chemotherapy on Quanlity of Life of Qi Deficiency and Blood Stasis Type Postperative Ovarian Carcinoma Patients, Fujian University of Traditional Chinese Medicine, 2012.
  8. W.-J. Chen, B. Wang, and X.-L. Han, “[Adjunctive therapy of hypopharyngeal carcinoma by Qingliu Lianghou Recipe].,” Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban, vol. 32, no. 7, pp. 892–895, 2012. View at Google Scholar · View at Scopus
  9. Y. H. Huang, A. J. Hu, Y. Zhou, and L. Gao, “Study on Yiqiyangyin Decoction combine with GP chemotherapy in advanced non-small cell lung cancer,” Journal of New Chinese Medicine, vol. 43, no. 9, pp. 47–49, 2011. View at Google Scholar
  10. M. F. Li, “To observe the curative effect of Yiqi Yangxue Decoction on bone marrow suppression after chemotherapy,” Shaanxi traditional Chinese Medicine, vol. no. 8, pp. 960-961, 2015. View at Google Scholar
  11. L. Jun, “Clinical Research on 58 Cases of Advanced Non-small Cell Lung Cancer Treated by the Intergrated TCM and Western Medicine [J],” Henan Traditional Chinese Medicine, vol. 6, p. 022, 2008. View at Google Scholar
  12. Y. Liu, clinical study on oophoroma after treated with fuzhengquyu decoction combined with chemotherapy, Heilongjiang University Of Chinese Medicine, 2008.
  13. Q. Z. L. J. Lu, K. Li, Q. Ji, and Y. J. Xue, “Clinical Observation of Wenshen Shengbai Decoction for Myelosuppression Induced by Chemotherapy for Postoperative Breast Cancer,” Journal of Shanghai University of Traditional Chinese Medicine, vol. 28, no. 3, pp. 29–31, 2014. View at Google Scholar
  14. Q. Sun, “Clinical observation of traditional Chinese medicine combined with chemotherapy in the treatment of advanced non small cell carcinoma,” Hainan Medical Journal, vol. 22, no. 15, pp. 31–33, 2011. View at Google Scholar
  15. X. Wu, “treatment of recurrent and metastatic breast cancer with combination of NP and Fuzhengxiaoyan decocotion,” Jilin Journal of Traditional Chinese Medicine, vol. no. 09, pp. 911–915, 2016. View at Google Scholar
  16. Z. Xu, C. Jin, and D. Shen, “Clinical study on treatment of advanced non-small-cell lung cancer with Chinese herbal medicine in different stages combined with chemotherapy,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 27, no. 10, pp. 874–878, 2007. View at Google Scholar
  17. Z. Y. Xu, C. J. Jin, C. C. Zhou et al., “Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy,” Journal of Cancer Research and Clinical Oncology, vol. 137, no. 7, pp. 1117–1122, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. L.-M. Zhu, H. Zhang, H. Zhou, C.-F. Pan, K.-P. Shen, and Z.-Y. Xu, “Time-effect relationship of kangliu zengxiao decoction in reducing chemotherapy-associated adverse reactions in patients with advanced non-small cell lung cancer,” Journal of Shanghai Jiaotong University (Medical Science), vol. 31, no. 6, pp. 797–801, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. World Health Organization, WHO Handbook for Reporting Results of Cancer Treatment, 1979.
  20. S. G. Li, H. Y. Chen, C. S. Ou-Yang et al., “The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis,” PLoS ONE, vol. 8, no. 2, Article ID e57604, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. A. R. Jadad, R. A. Moore, D. Carroll et al., “Assessing the quality of reports of randomized clinical trials: Is blinding necessary?” Controlled Clinical Trials, vol. 17, no. 1, pp. 1–12, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. J. P. T. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, “Measuring inconsistency in meta-analyses,” British Medical Journal, vol. 327, no. 7414, pp. 557–560, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. C. B. Begg and M. Mazumdar, “Operating characteristics of a rank correlation test for publication bias,” Biometrics, vol. 50, no. 4, pp. 1088–1101, 1994. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” British Medical Journal, vol. 315, pp. 629–634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. R. M. Harbord, M. Egger, and J. A. Sterne, “A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints,” Statistics in Medicine, vol. 25, no. 20, pp. 3443–3457, 2006. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  26. A. Bensoussan, N. J. Talley, M. Hing, R. Menzies, A. Guo, and M. Ngu, “Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial,” Journal of the American Medical Association, vol. 280, no. 18, pp. 1585–1589, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. T. S. K. Mok, W. Yeo, P. J. Johnson et al., “A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity,” Annals of Oncology, vol. 18, no. 4, pp. 768–774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Sun, X. Zhang, J.-Y. Nian et al., “Chinese Herbal Medicine as Adjunctive Therapy to Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, 2016. View at Google Scholar
  29. S. Chen, A. Flower, A. Ritchie et al., “Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: a systematic review,” Lung Cancer, vol. 68, no. 2, pp. 137–145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. Q.-Q. Chen, X. Han, W.-M. Wang, L. Zhao, and A. Chen, “Danggui Sini Decoction Ameliorates Myelosuppression in Animal Model by Upregulating Thrombopoietin Expression,” Cell Biochemistry and Biophysics, vol. 71, no. 2, pp. 945–950, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Liu, H. Tan, X. Zhang et al., “Hematopoietic effects and mechanisms of Fufang E'jiao Jiang on radiotherapy and chemotherapy-induced myelosuppressed mice,” Journal of Ethnopharmacology, vol. 152, no. 3, pp. 575–584, 2014. View at Publisher · View at Google Scholar · View at Scopus